3.10
0.03 (0.98%)
0.03 (0.98%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.03 | 0.98% | 3.10 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.02 | 2.98 | 3.1699 | 3.02 | 3.07 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.06 | 9.14 | 6.08 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,090 | 336,318 | $ 3.08 | $ 1,034,934 | 1,428,459 | 1.35 - 7.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:10 | 40 | $ 3.10 | USD |
Acer Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 43.15M | 13.92M | 9.12M | $ - | $ - | -2.91 | -1.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.15 | 3.1699 | 2.90 | 3.05 | 242,733 | -0.05 | -1.59% |
| 1 Month | 3.17 | 5.39 | 2.83 | 3.94 | 2,031,794 | -0.07 | -2.21% |
| 3 Months | 3.01 | 5.39 | 2.50 | 3.92 | 1,395,756 | 0.09 | 2.99% |
| 6 Months | 3.02 | 5.39 | 2.30 | 3.72 | 757,805 | 0.08 | 2.65% |
| 1 Year | 2.14 | 7.05 | 1.35 | 3.71 | 535,478 | 0.96 | 44.86% |
| 3 Years | 19.00 | 34.10 | 1.08 | 4.97 | 233,123 | -15.90 | -83.68% |
| 5 Years | 8.55 | 34.10 | 1.08 | 5.21 | 202,087 | -5.45 | -63.74% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
